The case of a 50-year-old man affected by a rhabdomiosarcoma metastatic lesion in the left flank Is reported. The patient was addressed to 50.4 Gy radiotherapy with concomitant chemotherapy in order to locally control the lesion. A Tri-60-Co magnetic resonance hybrid radiotherapy unit was used for treatment delivery and a respiratory gating protocol was applied for the different breathing phases (Free Breathing, Deep Inspiration Breath Hold and Final Expiration Breath Hold). Three intensity modulated radiation therapy (IMRT) plans were calculated and Final Expiration Breath Hold plan was finally selected due to the absence of PTV coverage differences and better organs at risk sparing (i.e. kidneys). This case report suggests that organs at risk avoidance with MRI-guided respiratory-gated Radiotherapy is feasible and particularly advantageous whenever sparing the organs at risk is of utmost dosimetric or clinical importance.
| INTRODUCTION
Several sources of geometric uncertainties exist in the radiotherapy process. Tumor motion represents a major source of uncertainty.
Particularly, breathing-induced tumor motion up to 2 cm is common in lung and upper abdomen and even larger excursions can occur. [1] [2] [3] To ensure an adequate coverage of the tumor with the intended dose, a margin for intra/inter-fraction patient changes (internal margin) and for setup uncertainties (setup margin) is added around the clinical target volume to obtain the planning target volume (PTV).
Strategies to account for this motion while minimizing PTV include breath hold or free-breathing (FB) respiratory tracking and gating techniques. In particular, breath hold technique can be guided by supporting the patient with dedicated systems, such as the active breathing co-ordinator system (Elekta, Stockholm, Sweden). All these methods require a technological link between the detection of tumor position during the breathing cycle and treatment delivery. For this purpose, invasively implanted fiducial markers are available but they are associated with additional risks, costs, and require specific expertise. Fiducial-less solutions based on surrogates of tumor motion, such as the body surface or the diaphragm, have been proposed; variations in the correlation between tumor movements and surrogate signals can lead, however, to uncertainties resulting in a poor treatment outcome. Real-time cine planar magnetic resonance imaging (MRI) offers the unique possibility to directly detect and gate the treatment to a particular condition of the respiratory cycle eliminating the need for surrogate-based systems and imaging dose to either breath hold or FB, depending on patient compliance and organs at risk (OARs) irradiation which may vary during the different conditions of the breathing cycle. 4 Even though a particular tumor may not show significant respiratory induced motion, remarkable changes may occur in the position of the surrounding OARs during the breathing cycle: this particular situation generally occurs when the target lesions are fixed (i.e., infiltrating tumors such as sarcomas)
or when spinal or bone metastases (more specifically of the axial skeleton) are treated. In such cases, gating the radiation treatment to the position of an OAR might offer a possibility for a further personalization of the treatment delivery.
The MRIdian ® system (ViewRay Inc., Cleveland, OHo, USA) is a hybrid machine that consists of two main components: a 0.35 Tesla MRI scanner and a radiation delivery system, composed either by a set of three Cobalt-60 (tri-Co-60) sources or a 6 MV linear accelerator, in its recently released MRI-Linac version. 5 The MRIdian ® system offers an integrated solution for online adaptive radiotherapy, allowing to modify the dose distribution taking into account the morphological changes occurring among different therapy days. 6, 7 In the next future, the online replanning could also be carried out on the basis possibly biological variations highlighted through advanced imaging analysis and diffusion weighted MRI sequences. 8, 9 A case where MRI-guidance has been successfully used to reduce normal tissue irradiation by performing the gating on an OAR is described in this report. To the best of our knowledge, this is the first study demonstrating the technical feasibility of this approach. The average intensity projection has been used for FB planning, while the aforementioned DIBH and FEBH CT scans for the respective respiratory condition. The GTV was expanded by 5 mm in all directions to create a PTV to account for delineation error, internal motion, and setup error.
| CASE DESCRIPTION
Considering the negligible movement observed for the primary lesion during the simulation condition and taking into account the foreseen maintenance chemotherapy that the patient would undergo after the radiochemotherapy treatment, we decided to preserve as much as possible the surrounding organs at risk and in particular the omolateral kidney, in order to reduce the risk of potential renal complications related to the expected further treatments.
Volumetric values for left kidney, GTV, and PTV for FB, DIBH, and FEBH plans are reported in Table 1 .
Three intensity modulated radiation therapy (IMRT) plans were calculated (FB, DIBH, and FEBH) and compared one to each other. In the absence of clear PTV coverage differences, FEBH plan was finally selected due to better OARs sparing, prioritizing the avoidance of the kidneys (Dmean) and more specifically of the omolateral (left) one. Table 2 reports all the dosimetric parameters taken into account for respiratory condition selection.
3.B | Treatment delivery
A daily setup 0.35 T MRI was acquired during FEBH at 1.5 mm isotropic spatial resolution and 17 s acquisition time. The MR images were registered by the attending physician with the treatment planning CT using a manual imaging registration method focusing on the GTV. After image fusion was satisfactorily accomplished, the couch was repositioned and a verification cine MRI in FEBH was performed over a period of 17 s before treatment delivery to check the reproducibility of the breathing condition. To this purpose the left kidney was selected as target structure for the gating giving an isotropic 4 mm boundary and gating the treatment to no more than 5% of the kidney out of boundaries. For MR-based real-time tracking of the sagittal plane, boundaries of 3-5 mm beyond the tracking structure have shown to be feasible with % ROI out of 2-10% for gating criteria. 10, 11 The lesion was placed at the center of the cine field of view to ensure the highest spatial integrity of the image.
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The chosen boundary values (4 mm) have been set starting from the measurements performed on a FEBH cine-MRI which showed that the left kidney lied in a 4 mm boundary area for more than 95% of the acquisition time.
The feasibility of the delivery settings (in terms of gating boundary and kidney out of boundary percentage) was tested during a dedicated preview analysis performed prior to each fraction: if the simulated beam on time resulted to be more than 70% of the monitored time with the chosen parameters, the treatment proceeded;
otherwise, the setup verification process had to be repeated. No online adaptations were performed in the treatment of this patient. Besides these technical advantages, the principal rationale of using this approach was the observation of a sound overall dosimetric benefit using a specific breathing condition for planning purposes. 
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